https://www.selleckchem.com/pr....oducts/nexturastat-a
001). Local recurrence was uncommon in both tumour subtypes when patients received definitive surgical excision (minimum histological margins of 10 mm as per institutional protocol) regardless of whether radiotherapy was used. The 5-year local recurrence-free survival for dermal leiomyosarcoma treated with radiotherapy was 93% versus 83% without radiotherapy (P = 0.7) and for subcutaneous leiomyosarcoma was 69% and 100%, respectively (P = 0.9). Conclusions Dermal leiomyosarcoma have an excellent prognosis, particularly after defin
Like
Comment
Share
